Difference between revisions of "Lestaurtinib (CEP-701)"
Jump to navigation
Jump to search
m |
m |
||
| Line 5: | Line 5: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | + | [[Category:Oral medications]] | |
| − | |||
[[Category:FLT3 inhibitors]] | [[Category:FLT3 inhibitors]] | ||
Revision as of 23:23, 23 February 2021
In clinical trials.
Also known as
- Code name: CEP-701